mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.0008 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |